Who has invested in MOMA Therapeutics?

Third Rock Ventures are named among the investors backing MOMA Therapeutics.

MOMA Therapeutics Funding: $86M Raised, Series B (2020)

MOMA Therapeutics funding overview

MOMA Therapeutics is based in Cambridge. MOMA Therapeutics has raised $86M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in April 2020. The round record for MOMA Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Third Rock Ventures.

MOMA Therapeutics at a glance

Total raised: $86M
Latest round: Series B
Latest round date: April 2020
Headquarters: Cambridge
Notable investors: Third Rock Ventures

Frequently asked about MOMA Therapeutics funding

How much has MOMA Therapeutics raised?: MOMA Therapeutics has raised $86M in total disclosed funding across the rounds on record.
Who has invested in MOMA Therapeutics?: Third Rock Ventures are named among the investors backing MOMA Therapeutics.
What was the latest MOMA Therapeutics funding round?: The most recent disclosed round is a Series B, announced in April 2020.
Where is MOMA Therapeutics based?: MOMA Therapeutics is based in Cambridge.
When did MOMA Therapeutics last raise?: The last disclosed MOMA Therapeutics round closed in April 2020 at Series B.

Totals shown for MOMA Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.

MOMA Therapeutics Funding: $86M Raised, Series B (2020)

MOMA Therapeutics funding overview

MOMA Therapeutics at a glance

Frequently asked about MOMA Therapeutics funding

Companies related to MOMA Therapeutics (36)

Browse related funding lists (6)